MIMS Editor Urges India Ban On ‘Bribes’ By Drug Makers To Physicians
This article was originally published in PharmAsia News
India should copy the U.S. law that requires drug makers to reveal their contributions to physicians who prescribe their drugs, according to an official of the Monthly Index of Medical Specialties.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.